QA: Viking Therapeutics Inc. in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001607678_2017_Viking_Therapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001607678')"}

Graph

Absolute values for 0001607678, Viking Therapeutics Inc.

  xvar xval
0 AssetsCurrent 13,974,829
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 560,879
4 LiabilitiesCurrent 6,476,534
5 LiabilitiesNoncurrent 16,307
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 4,846,776
9 ResearchAndDevelopmentExpense 9,000,499
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -884,547
13 remainder_ComprehensiveNetIncome 478
  yvar yval
0 Assets 14,535,708
1 Liabilities 6,492,841
2 Expenses 13,847,275
3 Revenues 0
4 StockholdersEquity 8,042,867
5 NetIncome -14,731,822
6 ComprehensiveNetIncome -14,731,583
7 BaseVar 17,880,424
8 EconomicCapitalRatio -0.0854

Edgar->Model Mapping

Feature Distribution